Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Interventional × Enteral Nutrition × Clear all

Phase

Status

Sponsor Class

OTHER 16 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Cerebral Palsy 1

Interventions

pembrolizumab 856 Carboplatin 802 Paclitaxel 786 Gemcitabine 659 Cisplatin 636 Docetaxel 594 Bevacizumab 517 Pemetrexed 412 Nivolumab 404 Cyclophosphamide 403 Capecitabine 388 Fluorouracil 336 Dexamethasone 332 Rituximab 320 Oxaliplatin 287 Injections 284 atezolizumab 253 Trastuzumab 248 Cetuximab 234 Leucovorin 233 Irinotecan 218 130-nm albumin-bound paclitaxel 216 Prednisone 215 Doxorubicin 210 Ipilimumab 188 Lenalidomide 187 Fulvestrant 181 fludarabine 180 durvalumab 173 venetoclax 165

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07341464 2026-01-14

Blends

Société des Produits Nestlé (SPN)

Phase NA Recruiting

Cerebral Palsy, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡